About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in New York | 64 Studies

Clinical Trials SchizophreniaNew York

Schizophrenia Clinical Trials in New York

Find 64 clinical trials for schizophrenia near New York, New York. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 64 trials

Active not recruitingYoung Adults With Violent Behavior During Early Psychosis (Aim 2)This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.NCT05756855·New York, New York CompletedOnTrack>An Online Role-Playing Game for Young People With First Episode PsychosisThe research team will develop and test a prototype version of OnTrack\>An Online Role-Playing Game (OnTrack\>The Game or OTG), an online role-playing game designed for youth and…NCT03390491·New York, New York CompletedRemediation of Visual Perceptual Impairments in People With SchizophreniaThe purpose of this study is to evaluate the effectiveness of a visual remediation intervention for people with schizophrenia.NCT03314129·Rochester, New York and 1 other CompletedKuvan in People With Schizophrenia and Schizoaffective DisorderRater blinded trial of six weeks of Kuvan vs. multivitamin in 60 outpatients with schizophrenia or schizoaffective disorder.NCT01706965·New York, New York

Schizophrenia Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTo Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaAlthough currently marketed antipsychotic drugs are useful in the treatment of schizophrenia, efficacy and safety profiles need to be improved.NCT00007774·Tuscaloosa, Alabama and 17 others

CompletedLevetiracetam in Early PsychosisIn order to establish target engagement and identify an effective dose the investigators will conduct a placebo-controlled single-dose parallel group trial of levetiracetam 185 mg…NCT03129360·New York, New York

CompletedLong-Acting Injectable Risperidone in the Treatment of SchizophreniaIn the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be…NCT00132314·Tuscaloosa, Alabama and 18 others

TerminatedA Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX StudyThis study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013).NCT05211947·Anaheim, California and 302 others

CompletedClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning.NCT04846868·Garden Grove, California and 115 others

TerminatedTreatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)This study will test whether repetitive transcranial magnetic stimulation (rTMS) is helpful in treating negative symptoms and social deficits of schizophrenia.NCT00517075·New York, New York

CompletedClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning.NCT04846881·Bellflower, California and 126 others

CompletedTC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in SchizophreniaSchizophrenia affects approximately 1% of the population worldwide, and in about 80% of cases, it is a lifelong, disabling illness.NCT01003379·National City, California and 15 others

CompletedD-serine Augmentation of NeuroplasticitySchizophrenia is a major public health problem associated with cognitive deficits, such as short and long term memory, executive functioning, attention and speed of processing…NCT03711500·New York, New York and 1 other

TerminatedThis Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 MonthsThe objective of the study is to investigate the efficacy, safety and tolerability of BI 409306 once daily compared with placebo given for 28 weeks in patients with schizophrenia…NCT03351244·Phoenix, Arizona and 58 others

CompletedGlutamate Reducing Interventions in SchizophreniaParticipants will be administered several doses of pomaglumetad (POMA) (low and high doses) over 14 days to individuals at clinical high risk for developing psychosis and use…NCT03321617·New York, New York

CompletedTreatment of Psychosis and Agitation in Alzheimer's DiseaseClinically, many patients with AD show no response or minimal response to antipsychotics for symptoms of agitation/aggression or psychosis, or they have intolerable side effects…NCT02129348·Miami, Florida and 3 others

CompletedA Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic SchizophreniaThe primary objective of this study is to investigate whether a single infusion of intravenous sodium nitroprusside (0.5 μg/kg/min for 4 hours) is superior to placebo (5% dextrose…NCT02164981·Boston, Massachusetts and 3 others

CompletedAcceptance and Commitment Therapy for DelusionsSymptoms of schizophrenia have historically been treatment resistant despite advances in psychopharmacology.NCT00657631·New York, New York

CompletedEvent-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer SubjectsThis is an observational, non-interventional study that will recruit Healthy Volunteers (HV) and subjects with clinically confirmed Schizophrenia (SZ).NCT04025502·Garden Grove, California and 3 others

CompletedD-serine for the Schizophrenia ProdromeThe purpose of the study is to determine the safety and efficacy of D-serine as an early intervention treatment for the schizophrenia prodrome condition.NCT00826202·New Haven, Connecticut and 3 others

PreviousPage 3 of 4Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia